DARAEX
LIVE

Serial Number

99244594

Owner

imusyn GmbH & Co KG,

Attorney

Steven P. Fallon

Filing Date

Jun 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DARAEX Trademark

Serial Number: 99244594 • Registration: 8201735

DARAEX is a trademark filed by imusyn GmbH & Co KG, on June 20, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

imusyn GmbH & Co KG, (2 trademarks)

Feodor-Lynen-Straße 5
Hannover 30625 , DE

Entity Type: 28

Trademark Details

Filing Date

June 20, 2025

Registration Date

April 7, 2026

Published for Opposition

February 17, 2026

Goods & Services

Immunoassay reagents for medical use, diagnostic agents for medical use, diagnostic reagents for medical use, diagnostic substances for medical use, Reagents for blood grouping for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 21, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 18, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 18, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 18, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 17, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 12, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 12, 2025 GNSL
SUSPENSION LETTER WRITTEN
Nov 12, 2025 CNSL
ASSIGNED TO EXAMINER
Nov 7, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 20, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2025 NWOS
NEW APPLICATION ENTERED
Jun 20, 2025 NWAP